In short

Evidence on Chiari malformation has improved recently. US neurosurgical guidelines and an international consensus were published in the early 2020s, and in 2026 a randomized trial compared decompression with and without a dural patch in young people with a syrinx. Most other evidence still comes from observational studies.

On this page

Evidence on Chiari malformation has improved in the last few years. US neurosurgical guidelines and an international expert consensus were published in the early 2020s, and in 2026 the first large randomized trial compared two versions of the standard operation. Most of the remaining evidence comes from observational studies, which describe what happened to patients but can't show what would have happened with a different treatment.

Guidelines and consensus

The Congress of Neurological Surgeons published guidelines on diagnosis1, symptoms2 and surgery3 in 2023, based on literature up to January 2021. Most recommendations are Grade C, based on Class III evidence, meaning the supporting studies were observational. An international consensus on adults reached agreement on 57 of 63 statements4, and a commentary on it described the lack of randomized evidence and the persistence of disputed indications5. The International Classification of Headache Disorders defines the Chiari headache and the MRI criteria, and states that its criteria need validation6.

StudyDesignSizePopulationMain findingLimitation
Bauer et al. 2023guidelinen/aChildren and adults with Chiari I; literature to January 2021.After diagnosis on brain or cervical MRI alone, further brain and spine imaging may help find hydrocephalus or a syrinx (Grade C, Class III evidence); cine MRI may or may not predict benefit from surgery.Grade C recommendations based on Level III evidence.
Jackson et al. 2023guideline35 studiesDecompression may relieve strain-related headache; no preventive surgery or activity limits without symptoms or a syrinx.Grade C recommendations based on Class III evidence.
Pattisapu et al. 2023guideline80 studiesDecompression with or without duraplasty are both acceptable first operations; reoperate on a persistent syrinx after 6 to 12 months.Literature to January 2021, before the 2026 randomized trial.
Ciaramitaro et al. 2022consensus statement31 experts and patient representatives; 63 statementsConsensus on 57 of 63 statements after two rounds; six needed a face-to-face meeting.Expert consensus, not new evidence; covers adults.
Massimi et al. 2023commentaryn/aDiffering opinions on indications leave patients "well-informed but disoriented".Expert commentary, written before the 2026 randomized trial was published.
Headache Classification Committee of the International Headache Society 2018classificationn/aDefines the Chiari headache: occipital, under 5 minutes, brought on by coughing or straining.The criteria themselves state that they need validation in prospective studies.

Surgery

The 2026 randomized trial in 162 young people with Chiari I and a syrinx found more improvement, more syrinx shrinkage and fewer repeat operations with duraplasty, with a complication rate that was higher but not significantly so7. Earlier meta-analyses compared dura-splitting with duraplasty8, pooled outcomes of surgery using intraoperative ultrasound9 and assessed tonsil reduction10.

StudyDesignSizePopulationMain findingLimitation
Limbrick et al. 2026randomized trial162 participants at 38 centersPeople aged 21 or younger with Chiari I (at least 5 mm descent) and a syrinx 3.0 to 9.9 mm wide; centers were randomized.Duraplasty: more improvement (58% vs 46%), more syrinx shrinkage and fewer repeat operations (3% vs 14%); complications 14% vs 6%, not significantly different.Children and young adults with a syrinx only; cluster randomization by center; the complication difference was not statistically significant.
Chang et al. 2021meta-analysis704 patients in 11 studiesNo difference in improvement or reoperation; fewer complications and shorter stays without opening the dura.Non-randomized studies, in which surgeons may have chosen the smaller operation for more favorable patients.
Hajikarimloo et al. 2026meta-analysis1,576 patients overall in 21 studies; outcome pools differPatients undergoing Chiari I surgery with intraoperative ultrasound; clinical improvement in 16 studies, syrinx improvement in 12, reoperation and complications in 20 each.With intraoperative ultrasound during Chiari I surgery: clinical improvement 88% (16 studies), syrinx improvement 87% (12 studies), reoperation 6% and complications 6% (20 studies each).Twenty-one non-randomized observational studies.
Lima et al. 2026meta-analysis1,527 patients in 10 studiesTonsil reduction improved outcome scores but nearly doubled the risk of meningitis.Comparative cohort studies; all outcomes rated low certainty.

Natural history and quality of life

A review of the epidemiology concluded that asymptomatic Chiari I far outnumbers symptomatic Chiari I and that the natural history appears benign11. The UK Chiari 1 Study found stable quality of life over a year without surgery12, and a US study followed scoliosis in children with Chiari I13.

StudyDesignSizePopulationMain findingLimitation
Holste et al. 2023literature reviewn/aAsymptomatic Chiari I far outnumbers symptomatic; the natural history appears benign.A narrative review.
Piper et al. 2026prospective cohort192 at baseline; 113 managed without surgery at 12 monthsAdults (16 and over) and children seen for the first time in UK neurosurgical clinics.Quality of life didn't decline over 12 months without surgery; some measures improved in adults.Observational, 12 months only, with dropout; can't compare surgery with observation directly.
Chotai et al. 2021cohort study43 childrenUnder-18s with Chiari I and a curve of at least 10°, from 14,118 children scanned at one US center.Curves stayed stable in 77%, progressed in 16% and regressed in 7% over about three years.Retrospective and single center, with few patients.

Anatomy and classification

A 2022 review covers the history, types and mechanisms of Chiari malformation14, and a 2026 imaging study examined the borderline Chiari 0 to 1.5 range15. The National Institute of Neurological Disorders and Stroke provides patient information on the types16.

StudyDesignSizePopulationMain findingLimitation
Rosenblum et al. 2022literature reviewn/aTypes I to IV are distinct malformations; Chiari I arises from a small posterior fossa.A narrative review.
Mirzayeva et al. 2026cohort study147 patientsTypes 0 to 1.5 are classified by tonsillar descent and the position of the lower brainstem (obex).Retrospective, single center.
National Institute of Neurological Disorders and Stroke 2026clinical referencen/aUS government patient reference on the types of Chiari malformation.Patient education page.

Reading Chiari research

  • Children and adults differ. The 2026 trial enrolled people aged 21 or under with a syrinx, and its results can't be assumed to apply to adults without one.
  • "Improvement" is defined differently. Some studies use the Chicago Chiari Outcome Scale, others surgeons' notes or patient questionnaires.
  • Selection shapes the results. In observational studies, surgeons choose techniques for particular patients, so differences between techniques can reflect who received them.
  • Symptoms and syrinx are separate outcomes. A syrinx can shrink without symptoms improving, and the reverse.

References

  1. Bauer DF, Niazi T, Qaiser R, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines for patients with Chiari malformation: diagnosis. Neurosurgery. 2023;93(4):723-726. doi:10.1227/neu.0000000000002633 Source ↩
  2. Jackson EM, Jernigan S, Raskin JS, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines for patients with Chiari malformation: symptoms. Neurosurgery. 2023;93(4):727-730. doi:10.1227/neu.0000000000002634 Source ↩
  3. Pattisapu JV, Ackerman LL, Infinger LK, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines for patients with Chiari malformation: surgical interventions. Neurosurgery. 2023;93(4):731-735. doi:10.1227/neu.0000000000002635 Source ↩
  4. Ciaramitaro P, Massimi L, Bertuccio A, et al; International Experts Jury of the Chiari Syringomyelia Consensus Conference. Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document. Neurol Sci. 2022;43(2):1327-1342. doi:10.1007/s10072-021-05347-3 PubMed ↩
  5. Massimi L, Vetrano IG, Peretta P, et al. Chiari malformation type 1 and syringomyelia: why do patients claim for international guidelines? Commentary on the 2021 Chiari and Syringomyelia Consensus Document. Acta Neurochir Suppl. 2023;135:139-145. doi:10.1007/978-3-031-36084-8_23 PubMed ↩
  6. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition: 7.7 Headache attributed to Chiari malformation type I (CM1). Cephalalgia. 2018;38(1):1-211. Accessed October 3, 2026. Source ↩
  7. Limbrick DD Jr, Shannon CN, Bayman EO, et al; Park-Reeves Syringomyelia Research Consortium Investigators. Decompression with or without duraplasty for Chiari I and syringomyelia. N Engl J Med. 2026;394(20):2015-2025. doi:10.1056/NEJMoa2402821 PubMed ↩
  8. Chang TW, Zhang X, Maoliti W, Yuan Q, Yang XP, Wang JC. Outcomes of dura splitting decompression versus posterior fossa decompression with duraplasty in the treatment of Chiari I malformation: a systematic review and meta-analysis. World Neurosurg. 2021;147:105-114. doi:10.1016/j.wneu.2020.11.163 PubMed ↩
  9. Hajikarimloo B, Mohammadzadeh I, Habibi MA, et al. Intraoperative ultrasonography in the surgical management of Chiari I malformation: a systematic review and meta-analysis of outcomes and applications. Neurol Sci. 2026;47(4):328. doi:10.1007/s10072-026-08879-8 PubMed ↩
  10. Lima GLO, Deus RMM, Massud JV, et al. Cerebellar tonsil manipulation in Chiari malformation type I surgery: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2026;261:109264. doi:10.1016/j.clineuro.2025.109264 PubMed ↩
  11. Holste KG, Muraszko KM, Maher CO. Epidemiology of Chiari I malformation and syringomyelia. Neurosurg Clin N Am. 2023;34(1):9-15. doi:10.1016/j.nec.2022.08.001 PubMed ↩
  12. Piper RJ, Afshari FT, Soon WC, et al; British Syringomyelia-Chiari Group and British Neurosurgical Trainee Research Collaborative. Quality-of-life outcomes in adults and children with Chiari 1 malformation and in those managed without surgery: a prospective, multicenter, observational study. Neurosurgery. 2026;98(5):1113-1128. doi:10.1227/neu.0000000000003718 PubMed ↩
  13. Chotai S, Nadel JL, Holste KG, et al. Longitudinal scoliosis behavior in Chiari malformation with and without syringomyelia. J Neurosurg Pediatr. 2021;28(5):585-591. doi:10.3171/2021.5.PEDS20915 PubMed ↩
  14. Rosenblum JS, Pomeraniec IJ, Heiss JD. Chiari malformation (update on diagnosis and treatment). Neurol Clin. 2022;40(2):297-307. doi:10.1016/j.ncl.2021.11.007 Source ↩
  15. Mirzayeva LS, Uçar M, Cindil E, Budak SN, Kuzucu P. Integrated neuroimaging approach to the Chiari malformation spectrum from type 0 to 1.5: correlations between CSF flow impedance, tonsillar blackout sign, obex position, and clinico-anatomical features. J Neuroradiol. 2026;53(2):101527. doi:10.1016/j.neurad.2026.101527 PubMed ↩
  16. National Institute of Neurological Disorders and Stroke. Chiari malformation. BrainFacts.org. Accessed October 3, 2026. Source ↩

Related pages